Stereotactic body radiotherapy for liver tumors Principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy

被引：84

作者：

Sterzing, Florian ^{[1
,2
]}

Brunner, Thomas B. ^{[3
]}

Ernst, Iris ^{[4
]}

Baus, Wolfgang W. ^{[5
]}

Greve, Burkhard ^{[4
]}

Herfarth, Klaus ^{[2
]}

Guckenberger, Matthias ^{[6
]}

机构：

[1] Deutsch Krebsforschungszentrum Dkfz, Klin Kooperat Einheit Strahlentherapie, D-69120 Heidelberg, Germany

[2] Radiol Univ Klin, Abt Radioonkol & Strahlentherapie, Heidelberg, Germany

[3] Univ Freiburg Klinikum, Radiol Klin, Klin Strahlenheilkunde, Freiburg, Germany

[4] Univ Klinikum Munster, Klin Strahlentherapie Radioonkol, Munster, Germany

[5] Univ Klinikum Koln, Klin & Poliklin Strahlentherapie, Cologne, Germany

[6] Univ Spital Zurich, Klin Radioonkol, Zurich, Switzerland

来源：

STRAHLENTHERAPIE UND ONKOLOGIE | 2014年 / 190卷 / 10期

关键词：

Liver SBRT; Radiosurgery; Focal liver irradiation; Liver metastases; Hepatocellular carcinoma; PHASE-I/II TRIAL; PRIMARY HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER METASTASES; RADIATION-THERAPY; HEPATIC RESECTION; SINGLE INSTITUTION; INTRAHEPATIC CHOLANGIOCARCINOMA; RADIOFREQUENCY ABLATION; SBRT; MOTION;

D O I：

10.1007/s00066-014-0714-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose. This report of the Working Group on Stereotactic Radiotherapy of the German Society of Radiation Oncology (DEGRO) aims to provide a practical guideline for safe and effective stereotactic body radiotherapy (SBRT) of liver tumors. Methods. The literature on the clinical evidence of SBRT for both primary liver tumors and liver metastases was reviewed and analyzed focusing on both physical requirements and special biological characteristics. Results. Recommendations were developed for patient selection, imaging, planning, treatment delivery, motion management, dose reporting, and follow-up. Radiation dose constraints to critical organs at risk are provided. Conclusion. SBRT is a well-established treatment option for primary and secondary liver tumors associated with low morbidity.

引用

页码：872 / 881

页数：10

共 50 条

[31] Stereotactic Body Radiotherapy
Niazi, Tamim
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 28 - 28
[32] Stereotactic radiotherapy of primary liver tumors and liver metastases
Bostel, Tilman
Bremer, Michael
ONKOLOGE, 2022, 28 (04): : 318 - 325
[33] Stereotactic Body Radiotherapy
Dahele, M.
McLaren, D. B.
CLINICAL ONCOLOGY, 2015, 27 (05) : 249 - 250
[34] Stereotactic Body Radiotherapy
Kollar, Laura
Rengan, Ramesh
SEMINARS IN ONCOLOGY, 2014, 41 (06) : 776 - 789
[35] Stereotactic Body Radiotherapy
Guckenberger, Matthias
ADVANCES IN RADIATION THERAPY, 2018, 44 : 67 - 88
[36] Practical patterns for stereotactic body radiotherapy to hepatocellular carcinoma in Korea: a survey of the Korean Stereotactic Radiosurgery Group
Bae, Sun Hyun
Kim, Mi-Sook
Jang, Won Il
Kay, Chul-Seung
Kim, Woochul
Kim, Eun Seog
Kim, Jin Ho
Kim, Jin Hee
Yang, Kwang Mo
Lee, Kyu Chan
Chang, A. Ram
Jo, Sunmi
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (04) : 363 - 369
[37] Individualized Stereotactic Body Radiotherapy of Liver Metastases
Guckenberger, Matthias
Flentje, Michael
STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (12) : 842 - 843
[38] Curative stereotactic body radiotherapy for liver malignancy
Peter Gunvén
Henric Blomgren
Ingmar Lax
Seymour H. Levitt
Medical Oncology, 2009, 26 : 327 - 334
[39] Curative stereotactic body radiotherapy for liver malignancy
Gunven, Peter
Blomgren, Henric
Lax, Ingmar
Levitt, Seymour H.
MEDICAL ONCOLOGY, 2009, 26 (03) : 327 - 334
[40] Stereotactic body radiotherapy in hepatocellular and cholangiocellular carcinoma (HCC, CCC): First results of the German Society of Radiation Oncology (DEGRO) working group "stereotactic therapy" cohort.
Brunner, T. B.
Ernst, I.
Blanck, O.
Andratschke, N.
Lewitzki, V.
Ganswindt, U.
Wachter, S.
Alheit, H.
Gkika, E.
Guckenberger, M.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 165 - 166

← 1 2 3 4 5 →